To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

Clinical trial NCT00659841 · COMPLETED

Trial details

NCT number: NCT00659841
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinitis, Allergic, Seasonal Hay Fever

Start date: 2003-12-01
Primary completion: 2004-12-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.